Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
Antibody-drug conjugates (ADC) utilizing the targeting properties of antibodies and therapeutic effects of drugs have emerged a rapid development in recent years. However, the relatively low drug loading capacity of ADC systems commonly results in failure in delivering enough chemical drugs to the d...
Saved in:
Main Authors: | Weiran Cao (Author), Rui Li (Author), Xing Pei (Author), Meihong Chai (Author), Lu Sun (Author), Yuanyu Huang (Author), Jiancheng Wang (Author), Stefan Barth (Author), Fei Yu (Author), Huining He (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
Improved method for synthesis of low molecular weight protamine-siRNA conjugate
by: Zhili Yu, et al.
Published: (2018) -
The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
by: Lei Zhang, et al.
Published: (2022) -
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
by: Borja Ballarín-González, et al.
Published: (2013) -
Dendrimers for siRNA Delivery
by: Swati Biswas, et al.
Published: (2013)